A Study to Evaluate the Bioequivalence of Tocilizumab Following Subcutaneous Administration Via an Autoinjector (AI 1000-G2) Versus a Pre-Filled Syringe in Healthy Volunteers

NCT02678988 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

189

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DEVICE: AI-1000 G2
DEVICE: PFS-NSD
DRUG: Tocilizumab

Sponsor

Hoffmann-La Roche